Louise van der Weyden, BSc (Hons), PhD

Senior Staff Scientist

Using comparative oncogenomics to understand the genetics of cancer in animals and humans

Comparative oncogenomics and 'One Medicine'

Comparative oncology is the comparison of spontaneously developed cancer in animals, typically pets (dogs and cats), to that seen in human cancer. Comparative oncogenomics specifically focuses on the comparison at a genetic/genomic level.

Many genetic alterations in animal and human cancers are ‘passenger events’ and not functionally important for cancer growth. However, by finding the same genetic alterations (mutations, copy number alterations, etc) in the same cancers across two species, we are using each species as a kind of ‘biofilter’ to select the alterations that have the greatest chance of being functionally relevant and not just ‘noise’. Identifying alterations that are common in both species gives us greater confidence they are biologically important for the cancer and should be targeted using anti-cancer therapies. We can also identify important differences between the species. This can help to determine if animals are good models of human cancer, and just as importantly, if humans are good models of animal cancer.

This is part of the ‘One Health, One Medicine’ approach, where veterinary and human medical research advance together for the benefit of both species; what we learn in one species, could be used to help the other.

My timeline

 

My publications

Loading publications...